In this study, we have established that G9a inhibition together with induction of low-level DNA damage by the DSB-inducing agents phleomycin or etoposide selectively impedes tumour cell growth without markedly affecting the growth of the normal epithelial cells or fibroblasts that we tested. Here, EHMT2 is linked to neoplasm.